Dextromethorphan Hydrobromide/Guaifenesin

氢溴酸右美沙芬/愈创甘油醚

Report date: 2023/02/10 10:17:08
NME

Base Information

Drug NameDextromethorphan Hydrobromide/Guaifenesin
Drug Alias Name氢溴酸右美沙芬/愈创甘油醚复方氢溴酸右美沙芬氢溴酸右美沙芬/愈创木酚甘油醚
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsCough
Global Approved IndicationsCough
Approved Indications in ChinaCough
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryUnited StatesMainland China
CombinationsYes Dextromethorphan HydrobromideGuaifenesin
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesReckitt Benckiser Group Plc
China Registration ClassN/A

Develop Information

Active CompaniesRB Health US LLCStade Pharmaceutical (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsCough
Inactive IndicationsN/A

Other Information

ATC CodeN07XX59
Related LinksN/A